Samedan Ltd Pharmaceutical Publishers


Advanced search

Publications European Pharmaceutical Contractor European Biopharmaceutical Review International Clinical Trials Pharmaceutical Manufacturing and Packing Sourcer Innovations in Pharmaceutical Technology Subscribe Online Conferences White Papers Samedan app Pharmaceutical Directory Industry Events Calendar News and Press Releases Employment Opportunities Advertising with us Contact Us

home > pmps > spring 2019 > the impact of falsified medicines

PUBLICATIONS

Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

Already registered? Please sign in.

Alternatively, please use our pay-per-view service.

News and Press Releases

Novo Nordisk Foundation Announces Support For New Open Collaborative Platform to Accelerate the Development of Plant-Based Foods

A new collaborative platform, Plant2Food, aims to accelerate the development of plant-based foods. Researchers and companies are invited to collaborate in exploring complex challenges within plant and food science and sharing new knowledge across sectors – without taking out patents based on the results. The Novo Nordisk Foundation is supporting the platform with up to €27 million over the next five years.
More info >>

All releases >>